Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study

Lupus Sci Med. 2022 Aug;9(1):e000786. doi: 10.1136/lupus-2022-000786.

Authors

Shu Ran^#¹, Lixin Pan^#², Baolin Liu²

Affiliations

¹ School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China shuran@usst.edu.cn.
² School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.

^# Contributed equally.

No abstract available

Keywords: COVID-19; epidemiology; lupus erythematosus, systemic.

Publication types

Letter

MeSH terms

COVID-19*
Humans
Lupus Erythematosus, Systemic* / complications
Lupus Erythematosus, Systemic* / epidemiology
Risk Factors